Testosterone replacement therapy: the honest guide

TL;DR

• TRT is legitimate for diagnosed hypogonadism - symptoms plus confirmed low testosterone, typically on two low morning readings, with LH/FSH to separate primary from secondary.
• It reliably improves libido, sexual function, energy, mood, muscle mass and bone density in genuinely deficient men - and does none of that as an "optimization" drug for normal levels.
• It suppresses your own production and impairs fertility while you are on it, and is usually a long-term commitment.
• TRAVERSE found testosterone non-inferior to placebo for major cardiac events in roughly 5,200 hypogonadal men at high cardiovascular risk.
• The FDA removed the cardiovascular boxed warning in February 2025 but added blood-pressure monitoring emphasis and kept the "Limitation of Use" for age-related low testosterone.
• Monitoring is part of the treatment - hematocrit, blood pressure, estradiol, prostate and sleep apnea.

Educational content for adults, not medical advice. No doses or protocols appear. TRT requires diagnosis, prescription, and ongoing monitoring by a physician.

---

Testosterone replacement therapy (TRT) is two very different things depending on who's taking it: for men with genuine, diagnosed deficiency (hypogonadism) it's a legitimate, effective treatment that restores sexual function, energy, mood, muscle and bone; for men chasing "optimization" of normal levels, it's largely hype with real downsides. The honest guide separates those, and it's timely - in 2025 the FDA reset TRT's safety labeling based on the large TRAVERSE trial, removing the old cardiovascular boxed warning while adding blood-pressure cautions. TRT is worth understanding clearly: who actually needs it, what it does and doesn't do, the commitment it involves (including fertility), and the risks to monitor. Here's the grounded picture.

Who TRT is actually for

TRT is for diagnosed hypogonadism - not "my energy's a bit low." Diagnosis means symptoms plus confirmed low testosterone (typically two low morning readings), and a clinician will also check LH/FSH to tell whether the problem is in the testes (primary) or the brain's signalling (secondary) - which changes the best treatment. The FDA explicitly retains a "Limitation of Use" for age-related low testosterone: dropping somewhat with age isn't automatically a disease to medicate. This matters because the foundations (sleep, weight, training, alcohol) move testosterone meaningfully and should be addressed first.

What it does - and doesn't

In genuinely deficient men, TRT reliably improves libido and sexual function, energy, mood, muscle mass and bone density. What it's not: a performance enhancer for men with normal levels, an anti-aging cure, or a fat-loss drug. And it comes with a defining trade-off - because external testosterone suppresses the brain's signal, it shuts down your own production and impairs fertility while you're on it (details here), and it's typically a long-term commitment.

The risks to monitor

TRT is manageable but not consequence-free - which is why monitoring is part of it:

The cardiovascular story - what 2025 changed

For a decade, TRT carried a cardiovascular cloud. The TRAVERSE trial (2023, ~5,200 hypogonadal men with high CV risk) was designed to settle it and found testosterone therapy non-inferior to placebo for major cardiac events. On that basis, the FDA in February 2025 removed the boxed warning language about heightened cardiac risk and added TRAVERSE to the labeling. The honest nuance: it's not a clean bill of health - the same update added blood-pressure monitoring emphasis (TRT can raise BP), and some analyses flag an arrhythmia signal. The fair summary: in appropriately selected, monitored hypogonadal men, TRT does not appear to raise overall cardiac-event risk - but BP and individual risk still matter.

TRT vs the alternatives

TRT isn't the only lever, and isn't always the first:

• Foundations first - natural optimization can be enough for borderline cases.
• Fertility a priority? Enclomiphene/clomiphene or HCG raise testosterone through your own axis, preserving fertility - often better for younger men.
• TRT when deficiency is real, fertility isn't the immediate concern (or is protected), and the alternatives don't fit.

The bottom line - and where to start

TRT is effective and legitimate for genuinely deficient men - and oversold as "optimization" for everyone else. It needs a real diagnosis (symptoms + confirmed low testosterone, with LH/FSH to classify it), it's a long-term commitment that suppresses fertility, and it requires monitoring (hematocrit, blood pressure, prostate, estradiol). 2025's evidence reset eased the cardiovascular fear for properly selected men but added blood-pressure caution. The right first step isn't a prescription off a quiz - it's testing to confirm whether you're actually deficient, and weighing TRT against the foundations and the fertility-preserving alternatives.

Explore it with verified supply. Every Vivre Labs lot is independently tested and the certificate of analysis is published, so you know exactly what is in the vial. Explore kisspeptin.

Frequently asked questions

Do I need testosterone therapy? Only if you have genuine hypogonadism - symptoms plus confirmed low testosterone on testing, not just age-related decline. The foundations (sleep, weight, training, alcohol) should be addressed first, and testing comes before any prescription.

Is TRT safe for the heart? The large TRAVERSE trial found testosterone therapy non-inferior to placebo for major cardiac events in monitored hypogonadal men, and the FDA removed the cardiovascular boxed warning in 2025. It's not risk-free - it can raise blood pressure and needs monitoring - but it doesn't appear to raise overall cardiac-event risk in appropriately selected men.

Is TRT permanent? It's typically a long-term commitment - and while you're on it, your own production is suppressed and fertility is impaired. Stopping requires a supervised restart, so it's a decision to make deliberately, especially if children are a possibility.

Related reading

• Does TRT cause infertility? · How to come off TRT and restart your axis · Enclomiphene vs HCG vs kisspeptin · How to boost testosterone naturally
• Part of The Complete Guide to Sexual Health & Hormonal Vitality

---

Educational content for adults, not medical advice. TRT requires diagnosis, prescription, and monitoring; individual risks vary. Claims for the Malaysian market are subject to MAB requirements.

References

• TRAVERSE trial: testosterone therapy non-inferior to placebo for MACE in hypogonadal men with CV risk (Lincoff et al., NEJM 2023). · FDA class-wide testosterone labeling changes, Feb 2025 - removal of CV boxed-warning language, addition of TRAVERSE results and blood-pressure monitoring; "Limitation of Use" for age-related hypogonadism retained. · TRT monitoring: hematocrit/erythrocytosis, blood pressure, prostate, estradiol. · European Expert Panel position statement on TRT cardiovascular safety (Andrology 2026).